Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
06/01/20242:00PMPR Newswire (Canada)Le gouvernement du Québec dévoile les résultats de la consultation sur la mobilité dans les régions de la Capitale-Nationale et de la Chaudière-Appalaches
06/01/20241:55PMPR Newswire (US)Back Nine Greens Announce a New Dealer: North Texas Luxury Lawns
06/01/20241:45PMPR Newswire (US)Karyopharm Presents Updated Exploratory Subgroup Analyses from SIENDO Study in Patients with Advanced or Recurrent TP53 Wild-Type Endometrial Cancer During 2024 ASCO Plenary Series: Rapid Abstract UpdatesNASDAQ:KPTIKaryopharm Therapeutics Inc
06/01/20241:42PMPR Newswire (Canada)Thrive with GBA | The Bay to Bay Dialogue held to deepen mutual understanding between China and US
06/01/20241:42PMPR Newswire (US)Thrive with GBA | The Bay to Bay Dialogue held to deepen mutual understanding between China and US
06/01/20241:10PMPR Newswire (US)Taseko Announces that Operations at its Gibraltar Mine have been SuspendedLSE:TKOTaseko Mines Limited
06/01/20241:10PMPR Newswire (US)Taseko Announces that Operations at its Gibraltar Mine have been SuspendedTSX:TKOTaseko Mines Limited
06/01/20241:10PMPR Newswire (Canada)Taseko Announces that Operations at its Gibraltar Mine have been SuspendedTSX:TKOTaseko Mines Limited
06/01/20241:10PMPR Newswire (Canada)Taseko Announces that Operations at its Gibraltar Mine have been SuspendedAMEX:TGBTaseko Mines Ltd
06/01/20241:10PMPR Newswire (US)Taseko Announces that Operations at its Gibraltar Mine have been SuspendedAMEX:TGBTaseko Mines Ltd
06/01/20241:02PMGlobeNewswire Inc.Affimed Provides Follow-up Data of AFM24 plus Atezolizumab Showing Durable Responses in Heavily Pretreated NSCLC EGFR Wild-type Patients and Positive Initial Data from the NSCLC EGFR Mutant CohortNASDAQ:AFMDAffimed NV
06/01/20241:01PMPR Newswire (US)PHILADELPHIA KICKS OFF PRIDE MONTH BY SETTING THE FIRST-EVER GUINNESS WORLD RECORDS™ FOR THE "LARGEST ATTENDANCE AT DRAG QUEEN STORY TIME"
06/01/20241:00PMPR Newswire (Canada)Canadian Coast Guard Welcomes 37 New Fleet Officers at College Graduation Ceremony
06/01/20241:00PMPR Newswire (Canada)La Garde côtière canadienne accueille 37 nouveaux officiers de la flotte lors de la cérémonie de remise des diplômes du Collège
06/01/202412:55PMGlobeNewswire Inc.Union members and allies mark Injured Workers’ Day in locations across Ontario
06/01/202412:36PMGlobeNewswire Inc.Prospera Energy Inc. Announces 2023 Financial ResultsTSXV:PEIProspera Energy Inc
06/01/202412:18PMPR Newswire (Canada)Favoriser le commerce et stimuler le développement : Promotion réussie de la 136e Foire de Canton aux États-Unis, au Canada et au Japon
06/01/202411:59AMPR Newswire (Canada)Boucherville renforce ses efforts en matière de sécurité nautique pour 2024
06/01/202411:51AMPR Newswire (US)CStone Announces European Medicine Agency CHMP Recommends Approval of Cejemly® (sugemalimab, anti-PD-L1) as First-Line Treatment for NSCLC
06/01/202411:49AMGlobeNewswire Inc.La Journée des Films thaïlandais à Paris captive le public parisien avec une première prestigieuse
06/01/202411:40AMPR Newswire (US)Z Grills Announces Unprecedented "Buy 1, Get 10 Grills" Promotion, Unlocking a Lifetime of Easier Grilling!
06/01/202411:23AMPR Newswire (Canada)Unifor members begin strike at Gibraltar copper mine
06/01/202411:00AMPR Newswire (US)ICECO Launches APL35 on Indiegogo - The World's Lightest Aluminum Dual-Zone Freezer
06/01/202410:34AMPR Newswire (US)The Agency's Agents Named Among Top Producers in the Country by RealTrends + Tom Ferry The Thousand 2024
06/01/202410:04AMPR Newswire (Canada)Déclaration des ministres Gary Anandasangaree, Patty Hajdu, Dan Vandal et Pascale St-Onge à l'occasion du Mois national de l'histoire autochtone
06/01/202410:00AMGlobeNewswire Inc.Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC)TG:GE9Genmab AS
06/01/202410:00AMBusiness WireInvestigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC)NASDAQ:GMABGenmab AS
06/01/202410:00AMBusiness Wire"Experience the Luxury of Japanese Tradition and Cuisine" Reservations for the New Inbound Experience Tour in Osaka's Tondabayashi Begin on June 1, 2024!
06/01/202410:00AMBusiness WireInvestigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC)NASDAQ:BNTXBioNTech SE
06/01/202410:00AMGlobeNewswire Inc.Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC)NASDAQ:BNTXBioNTech SE